Category | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
Gene Therapy Clinical Trials
|
NINDS
|
5R01NS032677-16
|
|
Genetically Engineered Viruses for Brain Tumor Therapy
|
MARTUZA, ROBERT
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$376,250
|
Gene Therapy Clinical Trials
|
NIA
|
1R01AG030048-01A1
|
|
A Phase 2 Trial of AAV-NGF Gene Delivery in Alzheimer's Disease
|
AISEN, PAUL
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$2,095,517
|
Gene Therapy Clinical Trials
|
NHLBI
|
5U01HL084877-03
|
|
Partners Heart Failure Network
|
STEVENSON, LYNNE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$569,493
|
Gene Therapy Clinical Trials
|
NIDCR
|
5K23DE016110-05
|
|
Defensin Gene Cluster Variation & Candida Carriage
|
JUREVIC, RICHARD
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$129,870
|
Gene Therapy Clinical Trials
|
NIAMS
|
5R01AR051085-04
|
|
Transfer of IL-1Ra cDNA to Osteoarthritic Knee
|
EVANS, CHRISTOPHER
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$113,710
|
Gene Therapy Clinical Trials
|
NCI
|
5R44CA107745-04
|
|
Clinical study of AdV-tk radiogene therapy for malignant glioma
|
AGUILAR-CORDOVA, ESTUARDO
|
ADVANTAGENE, INC
|
MA
|
$794,415
|
Gene Therapy Clinical Trials
|
NEI
|
5U10EY017280-03
|
|
Clinical trials of gene therapy for Leber congenital amaurosis
|
JACOBSON, SAMUEL
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$1,553,514
|
Gene Therapy Clinical Trials
|
NIAMS
|
1U54AR056953-01
|
0003
|
Adeno-associated Virus Vectors for Targeted and Repeat Delivery
|
SAMULSKI, RICHARD
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$337,966
|
Gene Therapy Clinical Trials
|
NICHD
|
5P01HD032652-13
|
9001
|
Core--Microchemical
|
BROWN, CHARLOTTE
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$25,358
|
Gene Therapy Clinical Trials
|
NIDDK
|
5P30DK047754-15
|
9005
|
Core--Human Applications
|
RAMSEY, BONNIE
|
UNIVERSITY OF WASHINGTON
|
WA
|
$142,980
|
Gene Therapy Clinical Trials
|
NIDDK
|
5P30DK065988-05
|
9003
|
Core--Imaging and Histology
|
DAVIS, C.
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$177,228
|
Gene Therapy Clinical Trials
|
NCI
|
5P50CA097257-07
|
0004
|
Exploiting the P13 Kinase Pathway in Human Glioma Therapy
|
STOKOE, DAVID
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$324,198
|
Gene Therapy Clinical Trials
|
NEI
|
5P30EY016665-04
|
9001
|
CORE--GENE DELIVERY/QUANTITATIVE MOLECULAR BIOLOGY
|
BRANDT, CURTIS
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$205,638
|
Gene Therapy Clinical Trials
|
NHLBI
|
5P01HL053586-14
|
9002
|
Vector
|
CORNETTA, KENNETH
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$156,667
|
Gene Therapy Clinical Trials
|
NCI
|
5P01CA059350-15
|
9004
|
Gene Transfer and Somatic Cell Engineering Core
|
RIVIERE, ISABELLE
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
NY
|
$693,977
|
Gene Therapy Clinical Trials
|
NHLBI
|
N01HV78204-1-0-1
|
|
NHLBI GTRP Lentivirus Vector Production Core Laboratory
|
NO PI IDENTIFIED
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$795,274
|
Gene Therapy Clinical Trials
|
NHLBI
|
N01HV78203-4-0-1
|
|
NHLBI GTRP AAV Vector Production Core Laboratory
|
NO PI IDENTIFIED
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
PA
|
$426,292
|
Gene Therapy Clinical Trials
|
NINDS
|
5P30NS057105-03
|
9004
|
Washington University Center for Translational Neuroscience
|
SANDS, MARK
|
WASHINGTON UNIVERSITY
|
MO
|
$210,139
|
Gene Therapy Clinical Trials
|
NHLBI
|
5P01HL066941-08
|
0001
|
Adenylyl Cyclase Type VI for CHF
|
HAMMOND, H. KIRK
|
VETERANS MEDICAL RESEARCH FDN/SAN DIEGO
|
CA
|
$799,834
|
Gene Therapy Clinical Trials
|
NCI
|
5P01CA097012-05
|
0003
|
Suicide Gene and Radiation Therapy Clinical Trials
|
KIM, JAE HO
|
HENRY FORD HEALTH SYSTEM
|
MI
|
$414,231
|
Gene Therapy Clinical Trials
|
NCI
|
5P01CA097012-05
|
9003
|
CORE--Biostatistics and Data Management Core
|
LU, MEI
|
HENRY FORD HEALTH SYSTEM
|
MI
|
$109,111
|
Gene Therapy Clinical Trials
|
NCI
|
5P50CA126752-02
|
9003
|
Cell and Vector Production
|
GEE, ADRIAN
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$151,560
|
Gene Therapy Clinical Trials
|
NINDS
|
5U54NS055958-02
|
0001
|
Dystrophin Restoration
|
MENDELL, JERRY
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
OH
|
$341,924
|
Gene Therapy Clinical Trials
|
NINDS
|
5U54NS055958-02
|
0002
|
CT GalNAc Transferase Gene Theraphy For DMD
|
MARTIN, PAUL
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
OH
|
$341,924
|
Gene Therapy Clinical Trials
|
NCRR
|
5M01RR000082-46
|
7212
|
CLINICAL TRIAL: PHASE I TRIAL OF INTRAMUSCULAR INJECTION OF RAAV1-CB-HAAT
|
BRANTLY, MARK
|
UNIVERSITY OF FLORIDA
|
FL
|
$26,556
|
Gene Therapy Clinical Trials
|
NCRR
|
5M01RR000082-46
|
7241
|
PHASE I TRIAL OF OCULAR SUBRETINAL INJECTION OF A RAAV2-CB - HRPE65
|
BYRNE, BARRY
|
UNIVERSITY OF FLORIDA
|
FL
|
$55,823
|
Gene Therapy Clinical Trials
|
NCRR
|
5M01RR000188-44
|
7858
|
CLINICAL TRIAL: A PHASE I STUDY OF ADENOVIRAL VECTOR DELIVERY OF THE IL-12 GENE
|
MILES, BRIAN
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$1,561
|
Gene Therapy Clinical Trials
|
NCRR
|
5M01RR000188-44
|
7861
|
CLINICAL TRIAL: A PHASE I STUDY OF IN-SITU, NEOADJUVANT, PRE-RADICAL PROSTATECTO
|
KADMON, DOV
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$11,600
|
Gene Therapy Clinical Trials
|
NCRR
|
5U54RR019507-06
|
6949
|
PROJ 3: PSM: ABUSE, FELT STIGMA & ADHERENCE IN PLWHA
|
JIMENEZ, JUILO
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
PR
|
$270,604
|
Gene Therapy Clinical Trials
|
NIAID
|
5U54RR019507-06
|
6949
|
PROJ 3: PSM: ABUSE, FELT STIGMA & ADHERENCE IN PLWHA
|
JIMENEZ, JUILO
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
PR
|
$22,045
|
Gene Therapy Clinical Trials
|
NIMH
|
5U54RR019507-06
|
6949
|
PROJ 3: PSM: ABUSE, FELT STIGMA & ADHERENCE IN PLWHA
|
JIMENEZ, JUILO
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
PR
|
$15,363
|
Gene Therapy Clinical Trials
|
NCI
|
5P30CA006973-46
|
9033
|
CELL PROCESSING AND GENE THERAPY
|
JAFFEE, ELIZABETH
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$227,723
|
Gene Therapy Clinical Trials
|
NCI
|
5P50CA091846-08
|
0010
|
Improving Gene Therapy for Superficial Bladder Cancer
|
BENEDICT, WILLIAM
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$183,953
|
Gene Therapy Clinical Trials
|
NCI
|
5P50CA091956-08
|
0009
|
Gene Therapy of Prostate Cancer Using Radioactive Iodine
|
MORRIS, JOHN
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
MN
|
$177,573
|
Gene Therapy Clinical Trials
|
NIAID
|
1Z01AI000991-02
|
|
Gene Therapy Clinical Trials for Chronic Granulomatous Disease
|
KANG, ELIZABETH
|
NIH
|
|
$193,731
|
Gene Therapy Clinical Trials
|
NIAID
|
1Z01AI000992-02
|
|
Gene Therapy Clinical Trials for X-linked Severe Combined Immunodeficiency
|
DE RAVIN, SUK
|
NIH
|
|
$193,731
|
Gene Therapy Clinical Trials
|
NCI
|
1Z01BC010425-09
|
|
Analysis of Human Immune Reponses in Cancer Vaccine Clinical Trials
|
SCHLOM, JEFFREY
|
NIH
|
|
$650,466
|
Gene Therapy Clinical Trials
|
NCI
|
1Z01BC010615-04
|
|
RNAi Screening for the Systematic Discovery of Cancer Gene Function
|
CAPLEN, NATASHA
|
NIH
|
|
$170,751
|
Gene Therapy Clinical Trials
|
NCI
|
1Z01BC010945-01
|
|
Clinical trials employing cancer vaccine combination therapies
|
GULLEY, JAMES
|
NIH
|
|
$517,380
|
Gene Therapy Clinical Trials
|
NCI
|
1Z01BC010985-01
|
|
Gene therapy of cancer
|
ROSENBERG, STEVEN
|
NIH
|
|
$1,488,319
|
Gene Therapy Clinical Trials
|
NCI
|
1Z01BC010989-01
|
|
Clinical production of viral vectors for cancer gene therapy
|
FELDMAN, STEVEN
|
NIH
|
|
$384,967
|